Suppr超能文献

Dravet 综合征死亡率:日本患者的危险因素研究。

Mortality in Dravet syndrome: search for risk factors in Japanese patients.

机构信息

Department of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan.

出版信息

Epilepsia. 2011 Apr;52 Suppl 2:50-4. doi: 10.1111/j.1528-1167.2011.03002.x.

Abstract

A questionnaire survey was conducted in Japan to investigate the causes and prevalence of death related to Dravet syndrome. The questionnaire was delivered to 246 hospitals at which physicians were treating childhood epilepsy to gain information about the total number of patients with Dravet syndrome and the prevalence of early death due to the disorder. Responses to the survey were collected from 91 hospitals, and a total of 63 of 623 patients with Dravet syndrome had died. Data from 59 of these patients were analyzed. The age at death for these patients ranged from 13 months to 24 years and 11 months, with a median age of 6 years and 8 months. The causes of mortality included sudden death in 31 patients (53%), acute encephalopathy with status epilepticus (SE) in 21 patients (36%), drowning in 6 patients (10%), and other causes in one patient (1%). The incidence of sudden death reached a first peak at 1-3 years of age and a second peak at 18 years and older. In contrast, the incidence of acute encephalopathy with SE reached a peak at 6 years of age. Seven of the 10 patients who underwent SCN1A mutation analysis exhibited positive mutations but exhibited no consistent phenotype. The prevalence of Dravet syndrome-related mortality was 10.1%. The incidence of sudden death and acute encephalopathy with SE was higher in infancy (1-3 years) and at early school ages (with a peak at 6 years), respectively. Neither the treatment nor the number of seizures was associated with any cause of mortality. Factors leading to a fatal outcome are difficult to predict.

摘要

一项针对日本与 Dravet 综合征相关死亡原因和流行率的问卷调查表明,该问卷被发放给了 246 家正在治疗儿童癫痫的医院,以获取 Dravet 综合征患者的总人数以及因该疾病而导致的早期死亡流行率信息。该调查共收到了 91 家医院的回复,623 名 Dravet 综合征患者中共有 63 名死亡。对其中 59 名患者的数据进行了分析。这些患者的死亡年龄从 13 个月至 24 岁零 11 个月不等,中位年龄为 6 岁零 8 个月。死亡原因包括 31 名患者(53%)的猝死、21 名患者(36%)的急性脑病伴癫痫持续状态(SE)、6 名患者(10%)的溺水以及 1 名患者(1%)的其他原因。猝死的发生率在 1-3 岁时达到第一个高峰,在 18 岁及以上时达到第二个高峰。相比之下,急性脑病伴 SE 的发生率在 6 岁时达到高峰。进行 SCN1A 基因突变分析的 10 名患者中有 7 名显示阳性突变,但表现出无一致表型。Dravet 综合征相关死亡率为 10.1%。猝死和急性脑病伴 SE 的发生率在婴儿期(1-3 岁)和小学早期(以 6 岁为高峰)较高。治疗和癫痫发作次数均与任何死因无关。导致致命结果的因素难以预测。

相似文献

1
Mortality in Dravet syndrome: search for risk factors in Japanese patients.
Epilepsia. 2011 Apr;52 Suppl 2:50-4. doi: 10.1111/j.1528-1167.2011.03002.x.
2
Retrospective multiinstitutional study of the prevalence of early death in Dravet syndrome.
Epilepsia. 2011 Jun;52(6):1144-9. doi: 10.1111/j.1528-1167.2011.03053.x. Epub 2011 Apr 11.
3
Mortality in Dravet syndrome.
Epilepsy Res. 2016 Dec;128:43-47. doi: 10.1016/j.eplepsyres.2016.10.006. Epub 2016 Oct 26.
4
Mortality in Dravet syndrome: A review.
Epilepsy Behav. 2016 Nov;64(Pt A):69-74. doi: 10.1016/j.yebeh.2016.09.007. Epub 2016 Oct 11.
5
Defining Dravet syndrome: An essential pre-requisite for precision medicine trials.
Epilepsia. 2021 Sep;62(9):2205-2217. doi: 10.1111/epi.17015. Epub 2021 Aug 2.
6
A case of SUDEP in a patient with Dravet syndrome with SCN1A mutation.
Epilepsia. 2010 Sep;51(9):1915-8. doi: 10.1111/j.1528-1167.2010.02691.x.
7
Effects of vaccination on onset and outcome of Dravet syndrome: a retrospective study.
Lancet Neurol. 2010 Jun;9(6):592-8. doi: 10.1016/S1474-4422(10)70107-1. Epub 2010 May 4.
8
Early clinical features in Dravet syndrome patients with and without SCN1A mutations.
Epilepsy Res. 2012 Mar;99(1-2):21-7. doi: 10.1016/j.eplepsyres.2011.10.010. Epub 2011 Nov 8.
9
[Clinical and neuroimaging features of acute encephalopathy after status epilepticus in Dravet syndrome].
Zhonghua Er Ke Za Zhi. 2017 Apr 2;55(4):277-282. doi: 10.3760/cma.j.issn.0578-1310.2017.04.009.
10
Two autopsy cases of sudden unexpected death from Dravet syndrome with novel de novo SCN1A variants.
Brain Dev. 2020 Feb;42(2):171-178. doi: 10.1016/j.braindev.2019.10.005. Epub 2019 Oct 31.

引用本文的文献

1
Effectiveness of vagus nerve stimulation in Dravet syndrome: a case series.
Childs Nerv Syst. 2025 Jun 28;41(1):220. doi: 10.1007/s00381-025-06879-1.
2
Spotlight on mechanism of sudden unexpected death in epilepsy in Dravet syndrome.
Transl Psychiatry. 2025 Mar 17;15(1):84. doi: 10.1038/s41398-025-03304-8.
3
Voltage-gated sodium channels in excitable cells as drug targets.
Nat Rev Drug Discov. 2025 May;24(5):358-378. doi: 10.1038/s41573-024-01108-x. Epub 2025 Feb 3.
4
Fine mapping and candidate gene analysis of Dravet syndrome modifier loci on mouse chromosomes 7 and 8.
Mamm Genome. 2024 Sep;35(3):334-345. doi: 10.1007/s00335-024-10046-3. Epub 2024 Jun 11.
5
Cost Effectiveness of Adding Fenfluramine to Standard of Care for Patients with Dravet Syndrome in Sweden.
Appl Health Econ Health Policy. 2024 Jul;22(4):543-554. doi: 10.1007/s40258-024-00886-0. Epub 2024 May 17.
6
Fine Mapping and Candidate Gene Analysis of Dravet Syndrome Modifier Loci on Mouse Chromosomes 7 and 8.
bioRxiv. 2024 Apr 18:2024.04.15.589561. doi: 10.1101/2024.04.15.589561.
7
Cardiac-Specific Deletion of Scn8a Mitigates Dravet Syndrome-Associated Sudden Death in Adults.
JACC Clin Electrophysiol. 2024 May;10(5):829-842. doi: 10.1016/j.jacep.2024.01.003. Epub 2024 Feb 28.
8
Dravet syndrome: A systematic literature review of the illness burden.
Epilepsia Open. 2023 Dec;8(4):1256-1270. doi: 10.1002/epi4.12832. Epub 2023 Oct 11.
9
A registry for Dravet syndrome: The Italian experience.
Epilepsia Open. 2023 Jun;8(2):517-534. doi: 10.1002/epi4.12730. Epub 2023 Mar 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验